Liposomal formulations of anticancer drugs: selectivity and effectiveness.

Liposomal formulations of anticancer drugs: selectivity and effectiveness.

Item
http://www.wikidata.org/entity/Q34332785
Maurocalcine as a non toxic drug carrier overcomes doxorubicin resistance in the cancer cell line MDA-MB 231Nucleoside analogue delivery systems in cancer therapy.Liposome formulation of NSC-639829 using halothane as a solvent: a technical noteA method to determine the incorporation capacity of camptothecin in liposomes.Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation.Pharmacokinetics and tissue distribution of liposomal etoposide in rats.Entrapment of peptidoglycans and adamantyltripeptides into liposomes: an HPLC assay for determination of encapsulation efficiency.Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation.Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis
P2860

Liposomal formulations of anticancer drugs: selectivity and effectiveness.

Item
http://www.wikidata.org/entity/Q34332785
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Liposomal formulations of anticancer drugs: selectivity and effectiveness.
@ast
Liposomal formulations of anticancer drugs: selectivity and effectiveness.
@en
Liposomal formulations of anticancer drugs: selectivity and effectiveness.
@nl
type
label
Liposomal formulations of anticancer drugs: selectivity and effectiveness.
@ast
Liposomal formulations of anticancer drugs: selectivity and effectiveness.
@en
Liposomal formulations of anticancer drugs: selectivity and effectiveness.
@nl
prefLabel
Liposomal formulations of anticancer drugs: selectivity and effectiveness.
@ast
Liposomal formulations of anticancer drugs: selectivity and effectiveness.
@en
Liposomal formulations of anticancer drugs: selectivity and effectiveness.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Liposomal formulations of anticancer drugs: selectivity and effectiveness.
@en
P2093
P304
P31
P356
P433
P478
P577
P698